Molly Grammel is an associate in the firm’s Intellectual Property Litigation group. She has extensive trial experience, having participated in four federal trials since joining Goodwin in 2013. She focuses her practice on patent litigation, and has worked on software, hardware and Hatch-Waxman cases.




Ms. Grammel has worked on matters progressing to jury and bench trial in the Southern District of New York, the District of Delaware, the District of Massachusetts and the Eastern District of Missouri. She has also worked on appellate matters in the First Circuit and the Supreme Judicial Court of Massachusetts.

Representative matters include:

  • Reckitt Benckiser Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 14-1451-RGA (D. Del.). Representing Teva in Hatch-Waxman suit brought by Reckitt in response to Teva’s Abbreviated New Drug Application seeking approval to market a generic version of SUBOXONE® (buprenorphine/naloxone) sublingual films. Asserted patents included formulation and process claims.
  • AstraZeneca Pharmaceuticals LP et al. v. Teva Pharmaceuticals USA, Inc., No. 14-1478-GMS (D. Del.). Representing Teva in Hatch-Waxman suit brought by AstraZeneca in response to Teva’s Abbreviated New Drug Application seeking approval to market a generic version of BYETTA® (exenatide). Asserted patents included formulation and method of treatment claims.
  • Veracode, Inc. et al v. Appthority, Inc. (D. Mass.). Representing patent owner asserting patents relating to source code analysis and review in jury trial and post-trial proceedings.

In addition to her IP work, Ms. Grammel completed a six-month rotation with the Middlesex County District Attorney’s Office, during which she first chaired five jury trials, ten bench trials, and over a dozen evidentiary hearings. Ms. Grammel was also one of the Goodwin attorneys working on the 2014 criminal trial defense of former SAC Capital Advisors portfolio manager Mathew Martoma, then the largest-ever insider trading prosecution. Mr. Martoma faced charges that he obtained non-public information about the performance of a high-profile pharmaceutical clinical trial, and used this information to make trades resulting in profit and avoided losses of over $275 million.

Professional Activities

Ms. Grammel is a member of the Boston Bar Association, the American Bar Association and the National Association of Women Lawyers.


Ms. Grammel was a recipient of the Levy Scholarship, the University of Pennsylvania Law School’s largest merit award. She served as an Articles Editor for the University of Pennsylvania Journal of Constitutional Law, and was Vice President of the University of Pennsylvania chapter of Lambda Law. Ms. Grammel was also selected as a member of the Penn Law National Trial Competition team in 2013.

In The News

In den Nachrichten






J.D., 2013
University of Pennsylvania Law School
(magna cum laude)
B.A., 2010
University of California, Los Angeles
(magna cum laude, Phi Beta Kappa)





U.S. District Court for the District of Massachusetts
U.S. Court of Appeals for the First Circuit
Get In Touch
In Kontakt kommen
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers
Suche Andere Rechtsanwälte